Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inari Medical, Inc. (NARI)
NASDAQ:NARI
Holding NARI?
Track your performance easily
Earnings Data
Report Date
Mar 04, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.02Last Year’s EPS
-0.08Same Quarter Last Year
Based on 15 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 12, 2020
|% Change Since: 86.56%
|Next Earnings Date:Aug 11, 2020
Earnings Call Sentiment|Neutral
Inari Medical's Q3 2024 earnings call highlighted strong revenue growth, international expansion, and the upcoming PEERLESS study as significant positive developments. However, the company faced challenges with increased operating expenses and a net loss, suggesting a mixed but cautiously optimistic outlook.Company Guidance
During the Inari Medical Q3 2024 earnings call, the company reported a record revenue of $153.4 million, reflecting a 21.4% increase year-over-year. The global VTE revenue was $145.3 million, up 19.7% from the previous year, and the emerging therapies segment saw a 64% rise to $8 million. International sales also surged by 76.4%, totaling $11.5 million, driven primarily by European adoption. Gross margins were noted at 87.1%, slightly down from the prior year's 88.5%, due to product mix and international expansion costs. Operating expenses increased to $147.1 million, with R&D costs at $29.4 million and SG&A expenses at $108.3 million. The company raised its full-year revenue guidance to $601.5 million - $604.5 million, projecting growth between 22% and 22.5%. Inari reaffirmed its goal to achieve sustained operating profitability by the first half of 2025, anticipating breakeven GAAP operating income in Q4 of 2024.Record Revenue and Growth
In Q3, Inari Medical achieved record revenue of $153.4 million, representing a 21% year-over-year growth. The company raised its full-year revenue guidance and expects sustained operating profitability in the first half of 2025.
International and Emerging Therapies Expansion
Inari's international revenue reached $11.5 million, a 76.4% increase from the prior year, primarily driven by Europe. Emerging Therapies revenue was over $8 million, up 64% year-over-year.
PEERLESS Study and Market Opportunities
The upcoming PEERLESS study presentation is expected to enhance the adoption of FlowTriever. Inari sees a $150 million opportunity to convert catheter-directed thrombolytic procedures to mechanical thrombectomy.
Strong Gross Margins
Inari maintained a best-in-class gross margin of 87.1% for Q3 2024, showing sequential improvement over the previous quarter.
Advancements in New Products
The company launched its next-gen Artix system after receiving 510(k) clearance and commenced a limited market release, addressing a $600 million U.S. TAM.
---
NARI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
NARI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 28, 2024 | $42.56 | $49.18 | +15.55% |
| Jul 30, 2024 | $52.11 | $46.56 | -10.65% |
| Apr 30, 2024 | $37.34 | $41.60 | +11.41% |
| Feb 28, 2024 | $58.26 | $46.12 | -20.84% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Inari Medical, Inc. (NARI) report earnings?
Inari Medical, Inc. (NARI) is schdueled to report earning on Mar 04, 2025, TBA Not Confirmed.
What is Inari Medical, Inc. (NARI) earnings time?
Inari Medical, Inc. (NARI) earnings time is at Mar 04, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NARI EPS forecast?
NARI EPS forecast for the fiscal quarter 2024 (Q4) is -0.02.
---